Phase 1 Safety and Tolerability Study of Figitumumab combined with Pegvisomant in Patients with Advanced Solid Tumors
|Effective start/end date||5/1/09 → 5/31/15|
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.